9HM-13485-76469
4 vaccinations
6 coded responses
38 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 853 / AZ
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Pfizer-BioNTech
-
2021-03-12
Survey response — day 0, dose 1MedDRA: Coagulopathy — Feeling: GoodFree text: Blood clotting disorder (factor 5 Leiden, factor 2 Prothrombin)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-13
- 2021-03-14
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
-
2021-03-26
Survey response — day 14, dose 1MedDRA: Ovulation pain — Feeling: GoodFree text: Stronger than usual ovulation pain mid cycleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Dose 2 — Pfizer-BioNTech
- 2021-04-02
- 2021-04-03
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Joint painsAdult check-in
- 2021-04-05
- 2021-04-07
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-07-02
- 2021-10-02
-
2021-10-04
Dose 3 — Pfizer-BioNTech
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Back pain — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Lower back pain/kidney areaMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-13
- 2021-10-19
- 2021-10-26
-
2021-11-01
Survey response — day 28, dose 3MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Muscle spasms, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Painful period, cramps, prolonged bleeding · Healthcare visit (other): Arranged appointment with ObgynMedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Report sent to call center — day 28, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-11-09
- 2021-11-09
-
2021-11-16
Survey response — day 42, dose 3MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Reaction to previous exposure to any vaccine, Unevaluable event — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Stronger and longer period, lots of cramping during ovulation and prior to/during period. Same as after first (but not after second) vaccine. · Healthcare visit (other): Reached out to OB/GYN, will be seen Dec 1st. (had already scheduled well visit)MedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Report sent to call center — day 42, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-11-17
- 2022-01-03
-
2022-04-04
Survey response — 6 months, dose 3MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: GoodFree text: Stronger period bleeding, painful cramps, longer periods (5-8 days vs 3 days)MedDRA releases: 2024-11 · check-in free text available
-
2022-09-08
Dose 4 — Pfizer-BioNTech
- 2022-10-04
- 2022-10-09
- 2022-10-13
- 2022-10-22
- 2022-12-09
- 2023-03-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-09-08 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Blood clotting disorder (factor 5 Leiden, factor 2 Prothrombin)
Release 6 — day 14, dose 1
Symptoms: Stronger than usual ovulation pain mid cycle
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lower back pain/kidney area
Release 10 — day 28, dose 3
Symptoms: Painful period, cramps, prolonged bleeding
Healthcare visit (other): Arranged appointment with Obgyn
Release 10 — day 42, dose 3
Symptoms: Stronger and longer period, lots of cramping during ovulation and prior to/during period. Same as after first (but not after second) vaccine.
Healthcare visit (other): Reached out to OB/GYN, will be seen Dec 1st. (had already scheduled well visit)
Release 11 — 6 months, dose 3
Symptoms: Stronger period bleeding, painful cramps, longer periods (5-8 days vs 3 days)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Ovulation pain | ✓ | ✓ | ✓ |
| SD | Reaction to previous exposure to any vaccine | · | · | ✓ |
| SRO | Back pain | · | · | ✓ |
| SRO | Coagulopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release